KAYLA CURTIS: Open Payments
NPI 1891346334 · CROMWELL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,869 in 202 payments from 17 companies in 2025. Trend: 2023 $2,412 · 2024 $4,537 · 2025 $4,869
Food & beverage: $4,859Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,002 |
| Janssen Biotech, Inc. | 16 | $569 |
| LEO Pharma Inc. | 21 | $462 |
| GENZYME CORPORATION | 10 | $362 |
| PFIZER INC. | 24 | $355 |
| Amgen Inc. | 11 | $344 |
| UCB, Inc. | 13 | $312 |
| Incyte Corporation | 17 | $286 |
| Novartis Pharmaceuticals Corporation | 10 | $259 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $209 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ADBRY, DUPIXENT, CIBINQO, Otezla, Bimzelx.
Industry payments across CT — which companies pay providers there.
